The discrepancy of the PIK3CA mutation detection rate in tumor tissue of cervical adenocarcinoma among these reports were attributed to the differing purity of tumor cells in a sample, differing sensitivity of the measurement, or differing populations and regions as well as differing sample sizes. This evidence concerns the gene PIK3CA and neoplasm.